1Suppliers
4Customers
2Debt Items
17Related Chains

Source-Backed Evidence Depth

Semnur Pharmaceuticals, Inc. (SMNRW) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

7Total relationships
1Distinct source URLs
2High confidence
0.771Average confidence
2026-09-21Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Semnur Pharmaceuticals, Inc. Suppliers

TickerNameConfidenceEvidence
SCLXW SCLXW 72% Reciprocal relationship from SCLXW graph: Reciprocal relationship from SMNRW graph: Reciprocal relationship from SCLXW graph: Reciprocal relationship from SMNRW graph: Reciprocal relationship from SC…

Semnur Pharmaceuticals, Inc. Customers

TickerNameConfidenceEvidence
SCLX Scilex Holding Company 72% mparable option to purchase shares of Common Stock. As such, shares of Legacy Semnur common stock held by Scilex and Legacy Semnur stock options, respectively, were automatically cancelled in exchang…
SCLX Scilex Holding Company 72% Reciprocal relationship from SCLX graph: Reciprocal relationship from SMNRW graph: Reciprocal relationship from SCLX graph: Reciprocal relationship from SMNRW graph: mparable option to purchase share…
SCLXW SCLXW 72% mparable option to purchase shares of Common Stock. As such, shares of Legacy Semnur common stock held by Scilex and Legacy Semnur stock options, respectively, were automatically cancelled in exchang…
SCLXW SCLXW 72% Reciprocal relationship from SCLXW graph: operations of our suppliers. If contamination or other quality defects are discovered in our supply of ZTlido, GLOPERBA, ELYXYB or our product candidates or …

Semnur Pharmaceuticals, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
SMNRW-DEBT-12612 Xbrl Convertible 90% xbrl convertible detail from xbrl 2022-09-30.
SMNRW-DEBT-12611 Warrants outstanding: 7432122 90% xbrl warrant detail from xbrl 2025-12-31.

Semnur Pharmaceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Semnur Pharmaceuticals, Inc..

Semnur Pharmaceuticals, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Semnur Pharmaceuticals, Inc..

Semnur Pharmaceuticals, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SCLX Scilex Holding Company 100.00 1 ['customer']
SCLXW Scilex Holding Co 100.00 1 ['customer', 'supplier']
A Agilent Technologies, Inc. 50.00 2
AARD Aardvark Therapeutics, Inc. 50.00 2
BNY-PK Bank of New York Mellon Corp 50.00 2
COLL Collegium Pharmaceutical, Inc. 50.00 2
BMY Bristol-Myers Squibb Company 50.00 2
BMYMP Bristol-Myers Squibb Co 50.00 2
ORMP Oramed Pharmaceuticals Inc. 50.00 2
SMNR Semnur Pharmaceuticals, Inc. 50.00 2
SNYNF Sanofi 50.00 2
MCK McKesson Corporation 50.00 2
PAR PAR Technology Corporation 50.00 2
OISHI OISHI 50.00 2
DVLT Datavault AI Inc. 50.00 2
ITOCHU ITOCHU 50.00 2
ORANY ORANGE 50.00 2
🔐
SMNRW
Unlock SMNRW Supply Chain Data
Verified relationships include:
SCLXWSCLXWSupplier72%
SCLXScilex Holding CompanyCustomer72%
SCLXScilex Holding CompanyCustomer72%
+3 more relationships locked
Subscribe — View plans →